enGene Therapeutics Inc. (ENGN) Form 10-K Annual Reports
enGene Therapeutics Inc. (ENGN) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ENGN
CIK: 1980845
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 10/31
State: Z4
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 7/31/2023 12:00:00 AM
Lead Engagement PartnerMarc Plamondon
Audit LocationMontreal, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-24 | 2026-09-22 | 4 Filing | 0001552781-26-000501 | View SEC Doc Filr Page |
| 10-Q | 2026-09-08 | 2026-07-31 | 10-Q | 0001193125-26-384383 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001193125-26-384380 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352637 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000931 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003477 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0002005369-26-000051 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0001140361-26-032512 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-344559 | View SEC Doc Filr Page |
| 3 | 2026-07-22 | 2026-07-16 | 3 Filing | 0000929638-26-002667 | View SEC Doc Filr Page |
| 3 | 2026-07-22 | 2026-07-16 | 3 Filing | 0000929638-26-002666 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-22 | — | SCHEDULE 13G Filing | 0001636587-26-000058 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-17 | 8-K | 0001193125-26-307795 | View SEC Doc Filr Page |
| 8-K | 2026-07-16 | 2026-07-15 | 8-K | 0001193125-26-305418 | View SEC Doc Filr Page |
| 8-K/A | 2026-06-18 | 2026-06-16 | 8-K/A | 0001193125-26-275815 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0000929638-26-002263 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0000929638-26-002262 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0000929638-26-002261 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0000929638-26-002260 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0000929638-26-002259 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0000929638-26-002258 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0000929638-26-002257 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0000929638-26-002256 | View SEC Doc Filr Page |
| 10-Q | 2026-06-15 | 2026-04-30 | 10-Q | 0001193125-26-270386 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-13 | 8-K | 0001193125-26-270384 | View SEC Doc Filr Page |